Industry

Streamlined pharmaceutical workflows for precision and innovation

Leverage Labman’s cutting-edge automation to transform your pharmaceutical operations. Integrate our advanced technologies to enhance efficiency, precision, compliance, and scalability, empowering your teams to deliver high-quality therapies and drive innovation.

Start a custom project Explore our services

Orange pill pot is laid on its side on a wooden table, it has no lid on and the tablets have spilled out onto the table

Key services

Transform your pharmaceuticals lab processes with Labman’s advanced technological solutions.

Integrated end-to-end pharmaceutical automationOur systems automate pharmaceutical R&D from discovery to manufacturing. High throughput screening, parallel synthesis, sample preparation and real-time monitoring with Raman and HPLC to streamline drug development. Integrated with LIMS and ELNs, we ensure traceability, data integrity, and compliance, while automating process design, optimisation, and scale-up.

Custom CGT development workflowsLabman’s automated workflows support every stage of cell and gene therapy development - enabling seamless integration of liquid handling, high-throughput vector screening, and in-line analytics. From early construct design and cell engineering to potency testing and preclinical validation, our solutions streamline complex workflows with tools like automated cell thawing, qPCR, flow cytometry, and cell expansion. Tailored to viral vector production and engineered cell therapies, Labman’s solutions accelerate the path from design to functional validation.

Custom DMTA workflows for drug discoveryLabman’s automated DMTA workflows enhance medicinal chemistry with integrated solid and liquid handling, automated screening, and analysis. Systems for SAR analysis, mass spectrometry, and NMR enable quick validation, while tailored workflows streamline small-molecule and biologics discovery, accelerating the transition from design to experimental validation.

High-throughput screening & kinetic optimisationLabman’s automated platforms accelerate lead identification in drug development by integrating high-throughput screening, kinetic analysis, and advanced monitoring techniques for both small and large molecules. Equipped with tools like surface plasmon resonance (SPR), HPLC, LC-MS, and Raman spectroscopy, our systems enable real-time reaction monitoring, precise affinity ranking, stability profiling, and protein interaction analysis. Automated workflows streamline dose–response assays, solubility testing, aggregation analysis, and dynamic optimization, speeding up the characterization of small molecules, biologics, antibodies, enzymes, and other large-molecule therapeutics.

Advanced bioprocessing automationLabman’s bioprocessing systems support GMP-compliant, scalable therapeutic production. Automation for chromatography, viral inactivation, filtration, and cultivation ensures precision and regulatory compliance. Our modular solutions, using disposable fluid paths, integrate bioreactor monitoring, liquid handling, and process control, enabling seamless scaling from development to commercial manufacturing.

Analytical precision & purification automationOur automated purification systems utilise HPLC, UPLC, and LC-MS for high-fidelity compound isolation. Integrated fraction collection, re-suspension, and solubility testing support rapid isolation, while advanced mass spectrometry (MALDI-TOF) ensures precise drug quantification and integrity for both discovery and manufacturing. For large molecules, we can incorporate size-exclusion chromatography (SEC) and affinity chromatography to ensure the purity and stability of proteins, antibodies supporting both research and production needs.

AI-enhanced data management & connectivityLabman’s systems integrate with AI and data platforms, enhancing decision-making and workflow optimisation for both small and large molecules. For small molecules, our solutions enable precise tracking and analysis of compound libraries. For large molecules, we manage complex data for proteins, antibodies, and other biologics. Cloud-enabled solutions provide remote access and real-time monitoring, improving data flow and enabling continuous feedback to streamline drug development with greater precision.

Liquid handling & sample reformattingLabman’s liquid handling systems support a wide range of workflows for both small and large molecules. Our solutions facilitate precise sample preparation for cell line development, QC testing, and other critical processes. Whether using plates or tubes of any kind, our automated systems handle capping, de-capping, incubation, and reagent and media management with precision. This versatility enhances productivity and consistency across various stages of drug development and research.

Sample tracking & labellingLabman’s end-to-end automated systems ensure precise sample tracking and tube labelling for both small and large molecules. Our solutions integrate advanced barcode reading and tracking technologies, facilitating seamless management from discovery through GMP manufacturing. Whether handling small molecule libraries or large biomolecules, our systems provide reliable and efficient sample tracking, ensuring data integrity and compliance throughout the development process.

Optimising all aspects of your pharmaceutical process from R&D to manufacturing.

Labman’s pharmaceutical automation solutions support every phase of drug development, from discovery to manufacturing. Our systems streamline workflows, enhance reproducibility, and ensure compliance, allowing pharmaceutical companies to focus on innovation.

Woman wearing white lab coat having a conversation with a man wearing a white lab coat. They are stood behind a Labman robotic system and can be seen through the glass

Our Capabilties

Our mission is to enhance scientific pursuits with cutting-edge technology. Cultivating relationships with clients, some spanning over 25 years, emphasizes transparency and trust. Our dedicated team goes beyond transactions, actively engaging with clients for a profound understanding of project intricacies. This personalized approach distinguishes us and forms the foundation for consistently delivering technology that delights and inspires.

Hands-on team that will be your points-of-contact throughout the entire process of working with Labman.
Mechanical, electrical, electronics and software are all in-house at Labman, so you can always be kept up-to-date with where every component is in the project.
We keep an open door, so if you want to see your Labman technology at any stage in its development, you're always welcome to vist or to video call for updates.
We understand the importance of industry compliance with all our custom projects meeting GxP regulation and FDA data integrity standards.

Learn more about our capabilities

Accelerated discovery timelines, enhanced compound optimisation, and higher throughput for DMTA

Labman’s DMTA workflows streamline the drug discovery process with automated cycles of compound design, synthesis, testing, and analysis. This platform enables rapid, iterative optimization of compounds, supporting a wide range of assays like physicochemical profiling, dose-response testing, and structure-activity relationship (SAR) analysis. The integration of computational tools with experimental validation reduces the time from concept to lead candidate selection.

Fully automated Design, Make, Test, Analyze cycles for high-throughput drug discovery.
Integration with computational design tools and experimental validation workflows.
Multi-modal assay platforms for screening, SAR analysis, and physicochemical profiling.
Comprehensive support for both small molecules and biologics-driven drug discovery.

Custom CGT Development Workflows

Labman’s automated workflows support every stage of cell and gene therapy development, enabling seamless integration of liquid handling, high-throughput vector screening, and in-line analytics. From early construct design and cell engineering to potency testing and preclinical validation, our solutions streamline complex workflows with tools like automated cell thawing, qPCR, flow cytometry, and cell expansion.

• Seamless integration of liquid handling, vector screening, and in-line analytics.
• Automated workflows for early construct design, cell engineering, and potency testing.
• Tools like automated cell thawing, qPCR, flow cytometry, and cell expansion.
• Tailored solutions for viral vector production and engineered cell therapies.

Automated Synthesis and Reaction Kinetics Optimisation

The synthesis of novel pharma compounds demands speed, precision, and the ability to rapidly iterate. Our automated platforms provide scalable, integrated solutions for high-throughput synthesis, ensuring reproducibility and controlled conditions. By automating every aspect, including reaction monitoring and optimisation, we enable faster lead identification without compromising accuracy. Advanced in-situ monitoring tools give real-time insights into reaction kinetics, facilitating data-driven optimisation.

Fully integrated systems for small-molecule synthesis and biologics workflows.
Real-time reaction monitoring with advanced PAT tools like Raman spectroscopy and FLIR imaging.
High-throughput reaction screening platforms capable of testing hundreds of reactions simultaneously.
In-depth kinetic analysis with automated sampling and precise control of temperature, agitation, and irradiation.
Accelerated compound optimization, increased reproducibility, and deeper insights into reaction mechanisms.

Analytical and purification automation systems

Purity is critical in pharmaceutical compounds, and Labman’s automated purification platforms ensure high-quality isolation. From HPLC and UPLC to mass spectrometry (LC-MS and MALDI-TOF), our systems incorporate advanced purification and analytical technologies. High-throughput capabilities enable rapid compound isolation and characterisation, while innovative vial imaging tools provide precise analysis of solubility, phase behaviour, and sample integrity, ensuring consistent results.

Automated purification platforms for HPLC, UPLC, and mass spectrometry.
Advanced vial imaging and analysis for precise quantification of solubility and sample integrity.
Integration of high-throughput filtration, extraction, and re-suspension modules.
Real-time in-process analysis for accurate compound characterization.
Enhanced compound purity, efficient purification workflows, and reproducible results.

Formulation, Stability Testing, and Sample Preparation Automation

Labman’s automated systems streamline formulation and stability testing, critical for preclinical and clinical-phase research. Our systems support high-precision dosing, liquid handling, and homogenization, ensuring accurate formulations. Stability testing platforms monitor temperature, humidity, and photostability to assess formulation robustness. Fully compliant with GMP guidelines, these systems facilitate regulatory adherence while accelerating formulation development.

High-precision dosing, liquid handling, and homogenization for accurate formulations.
Automated stability testing systems for temperature, humidity, and photostability assessments.
Fully GMP-compliant systems, ensuring adherence to FDA, EMA, and ICH guidelines.
Automated vial filling, sealing, and long-term sample storage solutions.
Accelerated stability testing, robust formulations for clinical trials, and regulatory compliance.

Bioprocessing automation for therapeutic development

Labman’s bioprocess automation systems provide scalability and flexibility, integrating seamlessly into pharma manufacturing operations. Our GMP-compliant, modular skids are designed for biomanufacturing—from protein production to viral inactivation and filtration. They ensure smooth scaling from laboratory to commercial production while maintaining the highest standards of quality and data integrity. Our platforms comply with 21 CFR Part 11, ensuring comprehensive regulatory adherence and traceability.

Modular bioprocessing skids designed for scalability from discovery to manufacturing.
Full integration of purification processes including chromatography, filtration, and viral inactivation.
Compliance with GMP and 21 CFR Part 11 regulations for data integrity and traceability.
Seamless transition from lab-scale development to clinical and commercial-scale production.
Scalable solutions, improved data integrity, and enhanced flexibility in therapeutic manufacturing.

“The Labman staff were very welcoming, the facilities are fantastic and the information provided was of excellent quality. We hope to continue the good relationship that we've built up between the two companies.”

— Ben HoldenCerulean

Related projects

Yeah, we’ve probably built it.

We’ve produced 100s of unique pieces of revolutionary technologies for laboratories worldwide. Each of these harnesses Labman’s unique ability to design for a specific workflow and to integrate tools that customer’s know well in an automated way.

Explore portfolio